LAA epicardial device
Lariat
AtriClip
|
72.7% (n=16)
27.3% (n=6)
|
Age, years (Mean ± SD) |
68.2 ± 8.5 |
Female |
45.5% (n=10) |
BMI (Mean ± SD) [kg/m2] |
28.7 ±
2.7 |
Left Ventricle Ejection Fraction (LVEF) (%) |
54.5 ± 6.2 |
CHADS2 score (Mean ± SD) |
2.8±1.1 |
CHA2DS2- VASs score (Mean ± SD) |
4.3±1.7 |
HAS-BLED score ( Mean ± SD ) |
3.5±1.3 |
Congestive Heart Failure |
9.1% (n=2) |
Hypertension |
95% (n=21) |
Hyperlipidemia |
59.1% (n=13) |
Diabetes Mellitus 2 |
31.8% (n=7) |
Previous ischemic stroke/TIA |
72.7% (n=16) |
Hemorrhagic stroke |
9.1% (n=2) |
Myocardial infraction |
4.5% (n=1) |
Vascular Disease |
9.1% (n=2) |
Alcoholism |
9.1% (n=2) |
Laboratory parameters
Platelet count (103)
PT-INR
PT sec
PT %
APTT (sek)
Anti-Xa activity (IU/mL)
C-reactive protein (mg/L)
Total cholesterol (mmol/L)
LDL cholesterol (mmol/L)
HDL cholesterol (mmol/L)
Triglyceride (mmol/L)
Glycated hemoglobin (HBA1C) (%)
|
241.9±24
1.2±0.3
13.1±2.5
81.3±21.5
35.9±7.8
0.5±0.3
1.7±1.7
4.2±1.0
2.5±1.0
1.3±0.4
1.7±1.1
5.9±0.8
|